Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NascaCell Technologies
Martinsried, Bavaria, Germany
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
NascaCell Technologies was a Munich-based biotechnology company specializing in the development and application of aptamers, which are synthetic oligonucleotide ligands. The company utilized its proprietary "Aptashape" platform to identify high-affinity binders for a wide range of therapeutic targets, including proteins and small molecules. NascaCell operated both as a drug discovery entity and a contract research organization, providing screening services to pharmaceutical partners for target validation and lead identification. It was a spin-off from the Max Planck Institute for Biochemistry and was eventually acquired by AptaRes in 2006.
- Therapeutic areas
- Immunology
- Modalities
- AptamerSynthetic oligonucleotide
- Industry
- Biotech
02
Partnerships
Boehringer IngelheimMerck KGaAAltana Pharma
Beyond the preview
Go deeper on NascaCell Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NascaCell Technologies.